Biokine Therapeutics Ltd., BioLineRx Ltd. Granted U.S. Patent #11554159: Compositions And Methods For Treating Cancer
https://www.scribd.com/document/620316827/BLRX-Patent
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 53.2% to $0.31 during Thursday’s after-market session. Today’s trading volume…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock increased by 42.2% to $2.29 during Friday’s pre-market session. The company’s market cap stands…
BioLineRx Highlights Early-Stage Trial Data From Cancer Vaccine Candidate
BioLineRx Ltd (NASDAQ:BLRX) announced results from the Phase 1/2a study of the intratumoral cancer vaccine candidate AGI-134 in patients with unresectable…
Earnings Scheduled For November 15, 2022
Companies Reporting Before The Bell
• Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 97 companies made new 52-week lows.
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers
NexImmune (NASDAQ:NEXI) shares rose 38.8% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $16.9 million.
BioLineRx Has Received A Notice Of Allowance For Its U.S. Patent Application 16/866,588 Titled “Compositions And Methods For Treating Cancer”
https://patentcenter.uspto.gov/#!/applications/16866588/ifw/docs
